P2X7 mRNA expression in non-small cell lung cancer: MicroRNA regulation and prognostic value.
P2X7 mRNA expression in non-small cell lung cancer: MicroRNA regulation and prognostic value.
复制标题
DOI:
10.3892/ol.2014.2620
复制
发表时间:
2015-01
期刊:
影响因子:
2.9
通讯作者:
Fontanini G
中科院分区:
文献类型:
--
作者:
Boldrini L;Giordano M;Alì G;Melfi F;Romano G;Lucchi M;Fontanini G
The human P2X7 receptor is significant and exhibits several functions in neoplasia. At present, little is known with regard to its regulation. P2X7 expression may be regulated post-transcriptionally and putative microRNA (miRNA) binding sites are considered to be involved. The aim of this study was to determine whether miRNAs (miR-21, let-7 g and miR-205) regulate P2X7 mRNA stability. In addition, the impact of P2X7 expression in patients with non-small cell lung cancer (NSCLC) was investigated. P2X7 mRNA and mature Let-7 g, miR-21, and miR-205 expression levels were quantified in 96 NSCLC cases using quantitative reverse transcription polymerase chain reaction. In all samples, epidermal growth factor receptor and K-Ras mutational analysis was also performed. Samples with low P2X7 expression were found to exhibit a higher fold change in miR-21 expression when compared with samples exhibiting high P2X7 expression. Significantly higher miR-21 expression was observed in the tumors of NSCLC patients with a K-Ras mutation when compared with patients who had K-Ras wild-type tumors (P=0.003). Additionally, to evaluate the association between P2X7 expression and prognosis in NSCLC patients, survival analysis was performed using the Kaplan-Meier method. A significant difference in the progression-free survival and overall survival in the NSCLC patients with high P2X7 expression was identified, when compared with that of patients with low expression (P=0.03 and P=0.02, respetively). Therefore, we hypothesized that high levels of miR-21 expression in NSCLC patients with K-Ras mutations may be regulated by a complex circuit, including P2X7 downregulation and together these processes may promote tumor progression.
登录
查看更多内容
影响因子:
64.8
作者:
Lu, J;Getz, G;Golub, TR
通讯作者:
Golub, TR
影响因子:
4.2
作者:
Capodanno A;Boldrini L;Alì G;Pelliccioni S;Mussi A;Fontanini G
通讯作者:
Fontanini G
影响因子:
4.8
作者:
Zhou, Lingyin;Qi, Xiaoping;Gorodeski, George I.
通讯作者:
Gorodeski, George I.
影响因子:
2.9
作者:
Rahman, Omar Abdul;Sasvari-Szekely, Maria;Nemoda, Zsofia
通讯作者:
Nemoda, Zsofia
DOI:
10.1097/jto.0b013e318206a221
发表时间:
2011-02
期刊:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
影响因子:
--
作者:
Travis WD;Brambilla E;Noguchi M;Nicholson AG;Geisinger KR;Yatabe Y;Beer DG;Powell CA;Riely GJ;Van Schil PE;Garg K;Austin JH;Asamura H;Rusch VW;Hirsch FR;Scagliotti G;Mitsudomi T;Huber RM;Ishikawa Y;Jett J;Sanchez-Cespedes M;Sculier JP;Takahashi T;Tsuboi M;Vansteenkiste J;Wistuba I;Yang PC;Aberle D;Brambilla C;Flieder D;Franklin W;Gazdar A;Gould M;Hasleton P;Henderson D;Johnson B;Johnson D;Kerr K;Kuriyama K;Lee JS;Miller VA;Petersen I;Roggli V;Rosell R;Saijo N;Thunnissen E;Tsao M;Yankelewitz D
通讯作者:
Yankelewitz D